In this piece, we explore the practical approaches to pricing for value that pharma manufacturers can leverage today. Read More
Our global Life Sciences and Health Care team reports on current and evolving trends that are shaping the future of the industry. Read More
As we are passionate about bringing paradigm-shifting technologies to patients, we were excited by the opportunity to facilitate transatlantic collaborations between Boston’s biotech hub and the life Read More
In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More
This paper summarizes traditional methods of tracking excursions and presents an alternative automated method to track and resolve excursions in a more timely fashion that will reduce the time and costs associated with... Read More
With Syncade, Repligen has much better control of documents and revisions. Industry practice requires biannual review of controlled documents. The old system did not enforce this practice because the entire remind-and-review... Read More
Wondering what the new direct-to-patient shipping innovation is and how you next study could benefit? Read More
On January 19th, MassBio, at the request of the Joint Committee on Healthcare Financing, testified at the first in a series of informational sessions intended to provide legislators, stakeholders, and the public with a... Read More